Sponsored by:

Nuclear Medicine: Page 203

GE, Swedish firm collaborate on radiotracer program
By AuntMinnie.com staff writers
GE Healthcare and Swedish venture capital firm NXT2B have signed a joint financing agreement to develop a microscale radiotracer infrastructure that includes a cyclotron and PET tracer production.
April 18, 2012
FTC approves Cardinal nuclear pharmacy asset sale
By AuntMinnie.com staff writers
The Federal Trade Commission (FTC) said it has approved Cardinal Health's application to sell nuclear pharmacy assets to Patient Care Infusion.
April 18, 2012
GE gets FDA nod for Q.Freeze PET/CT software
By AuntMinnie.com staff writers
GE Healthcare has received U.S. Food and Drug Administration clearance for its Q.Freeze PET/CT quantitative imaging software.
April 17, 2012
Bayer to sell PET tracer portfolio to Indian firm
By AuntMinnie.com staff writers
Bayer Pharma is selling its portfolio of molecular imaging agents, including a PET tracer designed to detect early signs of Alzheimer's disease, to Indian healthcare conglomerate Piramal Healthcare.
April 15, 2012
Alzheimer's Assn. has concerns about Amyvid
By AuntMinnie.com staff writers
While the Alzheimer's Association supports the U.S. Food and Drug Administration's (FDA) recent clearance of Eli Lilly's Amyvid (florbetapir) radiopharmaceutical to view amyloid plaque in the brain, the organization is calling the use of the PET imaging agent a "double-edged sword."
April 10, 2012
FDA clears Amyvid for Alzheimer's use
By AuntMinnie.com staff writers
Eli Lilly and Avid Radiopharmaceuticals have received U.S. Food and Drug Administration (FDA) clearance for Amyvid, a molecular PET imaging agent used for imaging of beta-amyloid plaques in patients with cognitive impairment being evaluated for Alzheimer's disease and other causes.
April 8, 2012
Spectral Molecular nets $4M in financing
By AuntMinnie.com staff writers
Cascade Technologies and wholly owned subsidiary Spectral Molecular Imaging have signed an agreement for $4 million in financing.
April 4, 2012
ABIM's Choosing Wisely gains support
By AuntMinnie.com staff writers
Several more medical societies have joined the American Board of Internal Medicine (ABIM) Foundation's Choosing Wisely campaign to cut unnecessary healthcare utilization.
April 4, 2012
Navidea informed of Lymphoseek extension
By AuntMinnie.com staff writers
Radiopharmaceutical developer Navidea Biopharmaceuticals was notified by the U.S. Food and Drug Administration (FDA) that the Prescription Drug User Fee Act (PDUFA) date for its Lymphoseek radiopharmaceutical has been moved to Sept. 10.
April 2, 2012
GE, Dyax announce licensing agreement
By AuntMinnie.com staff writers
GE Healthcare and biopharmaceutical company Dyax announced a licensing agreement to develop and commercialize peptides binding to c-Met, a growth-factor receptor.
April 1, 2012
IBA Molecular deal finalized
By AuntMinnie.com staff writers
Ion Beam Applications (IBA) and SK Capital Partners, a New York City-based private investment firm, announced they have successfully completed their agreement to create IBA Molecular, a jointly owned company derived from IBA's worldwide radiopharmaceutical division.
April 1, 2012
BioClinica teams with Mirada for molecular imaging
By AuntMinnie.com staff writers
Clinical trial management firm BioClinica of Oxford, U.K., will partner with medical imaging software developer Mirada Medical to integrate Mirada's image analysis systems into BioClinica's PET and molecular imaging processes.
March 29, 2012
Previous Page
Page 203 of 440
Next Page